Article Text

Download PDFPDF

Increased disease activity in a patient with sarcoidosis after high dose interleukin 2 treatment for metastatic renal cancer
Free
  1. T F Logan1,
  2. E S Bensadoun2
  1. 1Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN, USA
  2. 2Division of Pulmonary and Critical Care Medicine, University of Kentucky, Lexington, KY, USA
  1. Correspondence to:
    Dr E S Bensadoun
    University of Kentucky, Division of Pulmonary and Critical Care Medicine, 740 South Limestone, K528 Kentucky Clinic, Lexington, KY 40536-0284, USA; ebens0uky.edu

Abstract

Sarcoidosis is a disease of unknown aetiology in which cytokines such as interleukin 2 (IL-2) are thought to play an important role. We present the case history of a 48 year old man with sarcoidosis who received treatment with high dose IL-2 for metastatic renal cell cancer, following which he developed hypercalcaemia characterised by a raised level of 1,25-dihydroxyvitamin D (1,25-(OH)2-D3), a finding consistent with sarcoidosis associated hypercalcaemia. The increased activity in his sarcoidosis following IL-2 treatment provides direct supportive evidence for the role of IL-2 in the pathogenesis of sarcoidosis.

  • sarcoidosis
  • hypercalcaemia
  • interleukin 2
  • renal carcinoma
  • hydroxychloroquine

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • * Conversion factors for SI units: creatinine: ×88.4 μmol/l; albumin: ×10 g/l; calcium (total): ×0.25 mmol/l; calcium (ionised): ×0.25 mmol/l; 1,25-(OH)2-D3: ×2.40 pmol/l.